Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.wockhardt.com | |
Market Cap | 2,850.23 Cr. | |
Enterprise Value(EV) | 4,485.23 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -36.15 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 242.54 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 0.82 | Calculated using Price: 197.85 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 14.41 Cr. | 144,060,153 Shares |
FaceValue | 5 | |
Company Profile | ||
The company is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. It has many research centres and several manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. It is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth today permeates every mind-set, process and techno-innovation within Wockhardt. |
1 Day |
|
-3.23% |
1 Week |
|
-9.03% |
1 Month |
|
-11.99% |
3 Month |
|
-17.39% |
6 Month |
|
-8.15% |
1 Year |
|
-45.46% |
2 Year |
|
-55.87% |
5 Year |
|
-76.44% |
10 Year |
|
-86.81% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 30.04 | 12.49 | 7.07 | -6.42 | -21.81 | -11.43 | -5.22 | -9.92 | -7.77 | |
Return on Capital Employed (%) | 18.98 | 11.25 | 6.87 | -0.31 | -5.47 | -2.87 | -1.11 | -5.50 | -1.96 | |
Return on Assets (%) | 13.36 | 5.84 | 3.25 | -2.69 | -7.93 | -4.01 | -1.80 | -3.93 | -3.71 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 3,581 | 3,715 | 3,775 | 3,337 | 2,852 | 2,675 | 2,672 | 3,376 | 3,849 | 3,494 | |
Non Curr. Liab. | 1,161 | 1,872 | 1,893 | 3,151 | 2,089 | 1,703 | 1,195 | 496 | 261 | 117 | |
Curr. Liab. | 1,743 | 1,773 | 1,842 | 1,979 | 2,692 | 2,864 | 3,497 | 3,121 | 3,207 | 3,246 | |
Minority Int. | 136 | 144 | 465 | 382 | 346 | 330 | 386 | 383 | 353 | 343 | |
Equity & Liab. | 6,622 | 7,505 | 7,976 | 8,849 | 7,978 | 7,571 | 7,749 | 7,376 | 7,670 | 7,200 | |
Non Curr. Assets | 3,266 | 3,983 | 4,024 | 4,314 | 4,599 | 4,756 | 5,320 | 4,951 | 5,081 | 4,938 | |
Curr. Assets | 3,356 | 3,522 | 3,952 | 4,535 | 3,380 | 2,815 | 2,401 | 2,425 | 2,589 | 2,262 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 6,622 | 7,505 | 7,976 | 8,849 | 7,978 | 7,571 | 7,749 | 7,376 | 7,670 | 7,200 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 4,830 | 4,482 | 4,453 | 4,015 | 3,937 | 3,566 | 2,844 | 2,708 | 3,230 | 2,783 | |
Other Income | 84 | 67 | 66 | 114 | 177 | 21 | 60 | 132 | 20 | 130 | |
Total Income | 4,915 | 4,548 | 4,519 | 4,129 | 4,114 | 3,587 | 2,904 | 2,840 | 3,250 | 2,913 | |
Total Expenditure | -3,851 | -3,772 | -3,959 | -4,002 | -3,992 | -3,604 | -2,746 | -2,771 | -2,932 | -2,677 | |
PBIDT | 1,064 | 776 | 560 | 127 | 122 | -17 | 158 | 69 | 318 | 236 | |
Interest | -83 | -55 | -129 | -225 | -255 | -265 | -276 | -249 | -299 | -309 | |
Depreciation | -140 | -145 | -142 | -149 | -150 | -164 | -224 | -246 | -247 | -250 | |
Taxation | -48 | -163 | -38 | 21 | -26 | 135 | 204 | 271 | 132 | 110 | |
Exceptional Items | 50 | -358 | -142 | -183 | -378 | ||||||
PAT | 843 | 413 | 252 | -226 | -667 | -312 | -138 | -297 | -279 | -591 | |
Minority Interest | -2 | -8 | -2 | 30 | 59 | 22 | -26 | -2 | 35 | 70 | |
Share Associate | 0 | 1 | |||||||||
Other Related Items | -139 | ||||||||||
Consolidated Net Profit | 702 | 405 | 251 | -196 | -608 | -195 | -69 | 686 | -244 | -521 | |
Adjusted EPS | 59 | 34 | 21 | -16 | -51 | -16 | -6 | 57 | -17 | -36 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 1,532 | 1,476 | 355 | 72 | -269 | 68 | 183 | 649 | -287 | 413 | |
Cash Fr. Inv. | 1,085 | -852 | -207 | -818 | -687 | 630 | 95 | -156 | 1,470 | -201 | |
Cash Fr. Finan. | -2,246 | -601 | -76 | 254 | 1,254 | -769 | -776 | -680 | -1,171 | -71 | |
Net Change | 372 | 23 | 73 | -492 | 298 | -71 | -499 | -186 | 12 | 141 | |
Cash & Cash Eqvt | 1,050 | 1,102 | 1,159 | 665 | 964 | 897 | 397 | 219 | 232 | 370 |
Wed, 18 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Details of Loss of Certificate |
Mon, 16 Jan 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for SBICAP Trustee Company Ltd |
Thu, 12 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate in terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter ended on 31st December 2022. |
Fri, 27 Jan 2023 |
|
|
|
|
|